| Organon GmbH - Taloxa, Suspension zum Einnehmen | | 52679 | | 01 | | Taloxa | | Suspension zum Einnehmen | | N03AX10 | | Felbamat | | 25.02.1997 | | |
| | Composition | | felbamatum 600 mg, cellulosum microcristallinum et carmellosum natricum, sorbitolum liquidum cristallisabile 1.5 g, glycerolum, polysorbatum 80, simeticoni emulsio, aromatica (Vanille) cum ethanolum 1.08 mg, saccharinum natricum, natrii benzoas 10 mg, propylis parahydroxybenzoas 1 mg, E 218 6.5 mg, aqua purificata, q.s. ad suspensionem pro 5 ml corresp. natrium 2.804 mg. | | Packungsbestandteile | | Suspension (orale) | | | | | | | | Principe actif | Concentr. |
|---|
| Felbamate | 600mg / 5ml |
| | BAG: Principe actif | Concentr. |
|---|
| Felbamate | 600 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| Aqua Purificata | | | | Aromatica (Vanille) cum Ethanolum | 1.08mg / 5ml | | | Carmellosum Natricum | | | | Cellulosum Microcristallinum | | | | E 218 | 6.5mg / 5ml | conserv. | | Glycerol | | | | Sodium Benzoate | 10mg / 5ml | | | Polysorbatum 80 | | | | Propylis Parahydroxybenzoas | 1mg / 5ml | | | Saccharinum Natricum | | | | Simeticoni Emulsio | | | | Sorbitolum Liquidum Cristallisabile | 1.5g / 5ml | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 028 | 230 ml | 94.26 | 118.95 | A | LS | Non |
|
|
